Karlsruhe, Germany – January 17^th, 2017 – the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery joimax^® announces again very satisfying growing sales figures. Record sales in 2016 are representing another 31% growth vs. 2015. This is in line with a Compound Annual Growth Rate (CAGR) from 2007 – 2016 of around 32%. Projections into 2017 show even accelerated growth due to the worldwide increasing adoption rate of the joimax^® procedures.

The company is busy on inventing and innovating next minimally invasive systems with regards to newer implants based on the EndoLIF^® technology but also decompression methods based on its endoscopic systems. This will now be completed with Intracs^®, the new Interaoperative Navigation Tracking & Control System with which joimax^® instruments can be navigated directly at the tip. The Intracs^® Navigation and Monitor Unit is integrated in the joimax^® Endoscopic Tower and all necessary tools are tailored for the TESSYS^® (transforaminal) and iLESSYS^® (interlaminar) procedures as well as for minimally invasive stabilization procedures, like EndoLIF^® (Lumbar Interbody Fusion) and Percusys^® (Percutaneous Screw-Rod Stabilization).

Karlsruhe, GER– July 15, 2019 –joimax^®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, announces the official sales launch of its complete EndoLIF^® family. EndoLIF^® is an instrument set for endoscopic-assisted minimally invasive lumbar interbody fusion. As already announced and showcased at earlier events, the EndoLIF^® product line consists of three members now: the well-known EndoLIF^® O/On-Cage, the EndoLIF^® Delta Cage, and the latest EndoLIF^® Double Wedge Cage. The complete EndoLIF^® product family is now CE-approved and fully available. Moreover, the EndoLIF^® O/On-Cage is FDA-approved.

All EndoLIF^® Implants are manufactured using a 3D printing process, which ensures an open diamond cell structure. The cages are safely implanted via the guide wire and are fillable with bone or bone substitute material. With their rough and porous surface, the implants guarantee optimal bone ingrowth, stability and finally fusion.

The EndoLIF^® Cage family provides the right implant for every patient and is the perfect solution for endoscopic spinal fusion. With the gentle and atraumatic access via gradual tissue dilatation, muscles remain intact leaving important biomechanical structures in place after surgery.

Like with any endoscopic procedure compared to open surgery, all advantages for fusion are now given with the EndoLIF^® program also. With one EndoLIF^® Instrument Set all three cages of the EndoLIF^® family can be implemented.

Dr. Florian Zentz, (Munich, GER) emphasizes “the extraordinarily high primary stability of the EndoLIF^® DoubleWedge-Cage”. He continues enthusiastically: “After insertion the cage sits very firmly in the intervertebral disc space and adjusts the angulation up to 18 degrees, almost directly enabling an optimal lordosis correction.”

Dr. Ralf Wagner, (Frankfurt, GER) is also convinced of the obvious advantages: “The Delta Cage is ideal for the posterior lumbar interbody fusion (PLIF) offering a gentle posterior alternative, especially at level L5-S1 with its large interlaminar window.

Karlsruhe (GER) — German-based joimax^®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce that it has received FDA clearance to market the EndoLIF^® Delta-Cage and EndoLIF^® DoubleWedge-Cage in the United States. Delta-Cages and DoubleWedge-Cages are intended for intervertebral body fusion procedures for various diseases of the lumbar spine, such as degenerative disc disease.

Many other experts including, Dr. Florian Zentz, head surgeon of the spine center in Tutzing (Munich), Dr. Ricardo Casal Grau, orthospine surgeon from Madrid, and Dr. J. N. Alastair Gibson, spinal surgeon from Edinburgh, supported the development of the joimax^® cages.

“With FDA clearance of two of our cages, our EndoLIF^® platform gets more complete; the next major step in endoscopic spinal surgery is endoscopically-assisted fusion,” says joimax^® Founder and CEO Wolfgang Ries. “More and more centers are proving the efficacy of these procedures in studies, demonstrating once again the major benefits of endoscopy in fusion. So far, our cages are well established in Europe and in selected centers in Asia, and now we are entering the USA, the biggest market for spinal fusion”.